Article (Scientific journals)
The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms
Rasamiravakaa, T.; Duez, Pierre; El Jaziri, M. et al.
2015In BioMed Research International, Article ID 759348
Peer Reviewed verified by ORBi
 

Files


Full Text
Tsiry Article final publié.pdf
Publisher postprint (2.08 MB)
Request a copy

All documents in ORBi UMONS are protected by a user license.

Send to



Details



Abstract :
[en] P. aeruginosa is an opportunistic pathogenic bacterium responsible for both acute and chronic infections. Beyond its natural resistance to many drugs, its ability to form biofilm, a complex biological system, renders ineffective the clearance by immune defense systems and antibiotherapy. The objective of this report is to provide an overview (i) on P. aeruginosa biofilm lifestyle cycle, (ii) on the main key actors relevant in the regulation of biofilm formation by P. aeruginosa including QS systems, GacS/GacA and RetS/LadS two-component systems and C-di-GMP-dependent polysaccharides biosynthesis, and (iii) finally on reported natural and synthetic products that interfere with control mechanisms of biofilm formation by P. aeruginosa without affecting directly bacterial viability. Concluding remarks focus on perspectives to consider biofilm lifestyle as a target for eradication of resistant infections caused by P. aeruginosa.
Disciplines :
Pharmacy, pharmacology & toxicology
Chemistry
Author, co-author :
Rasamiravakaa, T.
Duez, Pierre  ;  Université de Mons > Faculté de Médecine et de Pharmacie > Chimie thérapeutique et Pharmacognosie
El Jaziri, M.
Labtani, Q.
Language :
English
Title :
The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms
Publication date :
01 January 2015
Journal title :
BioMed Research International
ISSN :
2314-6133
Publisher :
Hindawi Publishing Corporation, United States
Volume :
Article ID 759348
Peer reviewed :
Peer Reviewed verified by ORBi
Research unit :
M136 - Chimie thérapeutique et Pharmacognosie
Research institute :
R550 - Institut des Sciences et Technologies de la Santé
Available on ORBi UMONS :
since 12 September 2014

Statistics


Number of views
5 (0 by UMONS)
Number of downloads
0 (0 by UMONS)

OpenCitations
 
286

Bibliography


Similar publications



Contact ORBi UMONS